Qualigen Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Aixcrypto Holdings

15/08/2023 14:11

* Qualigen Therapeutics Inc  QLGN.OQ  reported a quarterly
adjusted loss of 69 cents​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 52 cents per share.
    * Revenue rose 13.8% to $1.63 million from a year ago;
analysts
expected $1.60 million. 
    * Qualigen Therapeutics Inc's reported EPS for the quarter
was a
loss of 69 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Qualigen Therapeutics Inc shares had risen by 15.3% this
quarter and lost 18.5% so far this year.
    * The company reported a quarterly loss of $3.51 million.
    * Wall Street's median 12-month price target for Qualigen
Therapeutics Inc is $22.50 

This summary was machine generated from LSEG Refinitiv data
August 15 at 01:11 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.52          -0.69          Missed
 Sep. 30 2022      -1.30          -1.00          Beat